This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep 21;75(12):1036-7.

doi: 10.1212/WNL.0b013e3181f6f272. Epub 2010 Aug 25.

Biomarkers of PD progression: is CSF the answer?

Dag Aarsland¹, Bernard Ravina

Affiliations

PMID: 20739641
DOI: 10.1212/WNL.0b013e3181f6f272

Comment

Biomarkers of PD progression: is CSF the answer?

Dag Aarsland et al. Neurology. 2010.

. 2010 Sep 21;75(12):1036-7.

doi: 10.1212/WNL.0b013e3181f6f272. Epub 2010 Aug 25.

Authors

Dag Aarsland¹, Bernard Ravina

Affiliation

¹ Division of Psychiatry, Stavanger University Hospital, Arm Hansen v 20, N-4005 Stavanger, Norway. daarsland@gmail.com

PMID: 20739641
DOI: 10.1212/WNL.0b013e3181f6f272

No abstract available

PubMed Disclaimer

Comment on

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.
Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C. Siderowf A, et al. Neurology. 2010 Sep 21;75(12):1055-61. doi: 10.1212/WNL.0b013e3181f39a78. Epub 2010 Aug 18. Neurology. 2010. PMID: 20720189 Free PMC article.

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information